RadTran

RadTran is the operator of a biotechnology company that plans to develop and commercialize radioimmunotherapy for cancer. The company specializes in nuclear technologies that promote pharmaceuticals and energy production. Its patented technology helps extract targeted isotopes from naturally occurring reserves, filling a critical gap in the procurement of medical isotopes and enabling pharmaceutical companies to gain the means and confidence to develop new drugs.